TARIS Biomedical Obtains $15,000,000 Series A Funding

  • Feed Type
  • Date
    6/24/2009
  • Company Name
    TARIS Biomedical
  • Mailing Address
    99 Hayden Avenue Lexington, MA 02421
  • Company Description
    TARIS Biomedical Inc., a specialty pharmaceutical company with deep domain expertise in therapeutics and drug-delivery, is focused on local minimally-invasive drug-device convergence products. The TARIS core technology and development efforts are being applied to disease areas with high unmet medical need in which current therapies or systemic treatments have failed. TARIS Biomedical has several drug-device convergence program opportunities focused on addressing those underserved disease areas through local delivery of therapeutics, with an initial focus on bladder diseases including Interstitial Cystitis (IC)/Painful Bladder Syndrome (PBS)
  • Website
    http://www.tarisbiomedical.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $15,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Flagship Ventures
  • Venture Investor
    Flybridge Capital Partners
  • Venture Investor
    Polaris Venture Partners

By posting a comment, you agree to our terms and conditions.